T2 Biosystems, Inc. 4
4 · T2 Biosystems, Inc. · Filed Nov 9, 2015
Insider Transaction Report
Form 4
Harding David
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2015-10-30+146,600→ 146,600 totalExercise: $11.12Exp: 2015-10-30→ Common Stock (146,600 underlying)
Footnotes (1)
- [F1]25% of the total shares vest on 10/30/2016, and the remaining shares vest in substantially equal monthly installments over the following 36 months, to be fully vested on 10/30/2019.